Navigation Links
Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACC's 57th Annual Scientific Session
Date:3/26/2008

Presentation by Leader of Innovative Scripps Genomic Medicine Program to

Include Data on Novel Genomic Markers for Cardiac Disease

SAN DIEGO, March 26 /PRNewswire/ -- Eric J. Topol, M.D., chief academic officer of Scripps Health and director of the Scripps Translational Science Institute, will present a late-breaking lecture about advancements in the genomics of cardiovascular disease at the American College of Cardiology's (ACC) 57th Annual Scientific Session in Chicago.

Dr. Topol's presentation on March 31 will include data concerning new, compelling genomic markers for myocardial infarction, coronary artery disease, atrial fibrillation and abnormal lipoproteins. A panel discussion about the progress, limitations, caveats and future issues in cardiovascular genomic medicine will follow the presentation.

Who: Eric J. Topol, M.D., Chief Academic Officer, Scripps Health;

Director of Scripps Translational Science Institute; Professor of

Translational Genomics, The Scripps Research Institute

What: Late-breaking lecture about advancements in the genomics of

cardiovascular disease

When: 3:30 p.m.-4:30 p.m. CDT, March 31

Where: North Hall B1, McCormick Place, Chicago

About Scripps Genomic Medicine

An initiative of Scripps Health and The Scripps Research Institute, Scripps Genomic Medicine is an innovative program in which genomic researchers, clinicians and other specialists are working side-by-side to advance medicine. Current projects include the genotyping of tens of thousands of individuals of diverse ancestry to identify and define genes that are responsible for major disease and the underpinnings of health. Through The Scripps Translational Science Institute, this basic research will be translated into drug discovery programs and, ultimately, clinical trials. These trials, launched through Scripps Advanced Clinical Trials, will test
'/>"/>

SOURCE Scripps Health
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine news :

1. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
4. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
5. William F. Balistreri, M.D., honored with Distinguished Service Award by AASLD
6. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
8. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... 19, 2013 The Movement ... neurosurgeons, psychiatrists and urologists with specialists in physical ... works with patients and their family members to ... of life. Patients also have the opportunity to ... research. , “Movement disorders can be relentlessly progressive ...
(Date:6/19/2013)... Could drugs that block the body,s system for repairing ... to health? As unlikely as it may seem, those ... and breast cancers driven by a mutation in BRCA, ... revealed she carries the mutation. The compounds, termed PARP ... the current edition of Chemical & Engineering News ...
(Date:6/19/2013)... Research Triangle Park, NC (PRWEB) June 19, 2013 ... Entegrion , Inc., announced organizational changes to ... Chairman John B. Mowell said, “To support the ... of Directors has made changes to the Company’s ... advisors.” , The Company announced that ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2
... University Melvin and Bren Simon Cancer Center will ... health care solutions. WellPoint announced plans in ... to help improve patient care and support physicians ... personalized treatment decisions possible. It is estimated that ...
... the screw. That,s just a part of life for people, ... osteogenesis, a method to correct bone deformities that leave one ... University undergraduates has invented a device they hope will make ... Hospital for Children in Houston, the students came up with ...
... April 23 (HealthDay News) -- It goes without saying that ... they can also be very expensive, an expert warns. ... a person bitten by a venomous snake, said Jill Heatley, ... in College Station. The total cost includes hospitalization, which ...
... SAGE Launch Clinical Psychological Science ,Association for Psychological ... Angeles, CA (April 23, 2012) The Association for ... Clinical Psychological Science , a new peer-reviewed journal focused ... venue for cutting-edge research across a wide range of ...
... and American Associations for Dental Research have published ... articles, titled "Hypoplasia-Associated Severe Early Childhood Caries ... York University College of Dentistry) and "Deciduous Molar ... Elfrink, Academic Centre for Dentistry, Amsterdam) discuss the ...
... Guy, M.D., professor of ophthalmology at Bascom Palmer Eye ... Medicine, has pioneered a novel technological treatment for Leber ... causes rapid, permanent, and bilateral loss of vision in ... Genetic mutations in the mitochondria (part of the ...
Cached Medicine News:Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 2Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 3Health News:Rice University student engineers automate limb lengthening for kids 2Health News:Rice University student engineers automate limb lengthening for kids 3Health News:Cost of Snakebite Therapy May Squeeze Victims' Wallets 2Health News:Association for Psychological Science, SAGE launch Clinical Psychological Science 2Health News:IADR/AADR publish studies on severe early childhood caries - proposes new classification 2Health News:IADR/AADR publish studies on severe early childhood caries - proposes new classification 3Health News:Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder 2
(Date:6/19/2013)... June 19, 2013 Today MedeAnalytics, a ... the next-generation of its Employer Group and ... plans to provide their employer groups an intuitive ... medical and prescription drug claims, network utilization, and ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group and ...
(Date:6/19/2013)... FRANCISCO , June 19, 2013  It may seem ... possible cure for breast cancer. But these were two of ... Society,s 95 th Annual Meeting & Expo that just ... some are saying this focus by some of the top ... our culture,s obsession with new research that can not only ...
(Date:6/18/2013)...  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), ... and commercialization of novel bile acid therapeutics to treat ... underwritten public offering of 1,730,000 shares of its common ... share.  In addition, Intercept has granted the underwriters a ... shares of common stock. All of the ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... Aug. 27 Pharmacopeia,(Nasdaq: PCOP ), ... of novel,small molecule therapeutics, announced today that ... Special Program for Research and Training,in Tropical ... novel antimalarial,agents. Pharmacopeia will receive funding to ...
... have started a phase IIa clinical trial designed to ... C viral infection, one,of the toughest infectious diseases in ... which works as a,regulator of the body,s immune response, ... hepatitis C viral infection. "The drugs currently in ...
Cached Medicine Technology:Drug in New Hepatitis C Clinical Trial 2
... Wampole Laboratories offers a comprehensive line of ... serum and urine in convenient one-step stick ... 2 testing options. Clearview Easy HCG is ... convenient stick format. Clearview HCG II ...
The BioCheck hCG ELISA is intended for the quantitative determination of human chorionic gonadotropin (hCG) concentration in human serum. The assay is for use in the early diagnosis of pregnancy in a...
... preparation of whole blood is mixed continuously ... cation-exchange resin. During this time, HbAo binds ... a filter separator is used to remove ... contains glycohemoglobin. The percent glycohemoglobin is determined ...
The BioCheck Ferritin ELISA is intended for the quantitative determination of ferritin in human serum. This assay is to be used in the diagnosis of diseases affecting iron metabolism....
Medicine Products: